{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 0.54054, "regularMarketPrice": 3.72, "earningsTimestamp": 1678877940, "earningsTimestampStart": 1678877940, "earningsTimestampEnd": 1678877940, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.21, "epsForward": 0.09, "epsCurrentYear": -0.65, "priceEpsCurrentYear": -5.7230773, "sharesOutstanding": 12407100, "bookValue": 1.077, "fiftyDayAverage": 3.859, "fiftyDayAverageChange": -0.13899994, "fiftyDayAverageChangePercent": -0.03601968, "twoHundredDayAverage": 4.3946, "twoHundredDayAverageChange": -0.6745999, "twoHundredDayAverageChangePercent": -0.15350655, "marketCap": 46528644, "forwardPE": 41.333332, "priceToBook": 3.4540389, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1496818800000, "priceHint": 4, "marketState": "POSTPOST", "exchange": "PAR", "shortName": "VALBIOTIS", "longName": "Valbiotis SA", "messageBoardId": "finmb_343989318", "exchangeTimezoneName": "Europe/Paris", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "fr_market", "esgPopulated": false, "regularMarketChange": 0.01999998, "regularMarketTime": 1683905701, "regularMarketDayHigh": 3.73, "regularMarketDayRange": "3.67 - 3.73", "regularMarketDayLow": 3.67, "regularMarketVolume": 12900, "regularMarketPreviousClose": 3.7, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Paris", "financialCurrency": "EUR", "regularMarketOpen": 3.72, "averageDailyVolume3Month": 15001, "averageDailyVolume10Day": 21121, "fiftyTwoWeekLowChange": 0.9000001, "fiftyTwoWeekLowChangePercent": 0.319149, "fiftyTwoWeekRange": "2.82 - 6.88", "fiftyTwoWeekHighChange": -3.16, "fiftyTwoWeekHighChangePercent": -0.45930234, "fiftyTwoWeekLow": 2.82, "fiftyTwoWeekHigh": 6.88, "symbol": "ALVAL.PA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "rue Paul Vatine", "address2": "12th Floor ZI des Quatre Chevaliers", "city": "P\u00e9rigny", "zip": "17180", "country": "France", "phone": "33 5 46 28 62 58", "fax": "33 5 46 28 62 58", "website": "https://www.valbiotis.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestl\u00e9 Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in P\u00e9rigny, France.", "fullTimeEmployees": 48, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sebastien  Peltier HDR, Ph.D.", "age": 44, "title": "Co-Founder, Member of the Management Board & CEO", "yearBorn": 1978, "fiscalYear": 2021, "totalPay": {"raw": 259000, "fmt": "259k", "longFmt": "259,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sebastien  Bessy", "title": "COO & Member of the Management Board", "fiscalYear": 2021, "totalPay": {"raw": 104000, "fmt": "104k", "longFmt": "104,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Pascal  Sirvent Ph.D.", "title": "CSO & Member of the Management Board", "fiscalYear": 2021, "totalPay": {"raw": 194000, "fmt": "194k", "longFmt": "194,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Murielle  Cazaubiel", "title": "CMO & Member of the Management Board", "fiscalYear": 2021, "totalPay": {"raw": 207000, "fmt": "207k", "longFmt": "207,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Fedrick  Pelong", "age": 47, "title": "CFO & Member of the Management Board", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Josep  Infesta", "title": "Head of Global Bus. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}